Catelani Michael 4
4 · Anixa Biosciences Inc · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Catelani Michael
President, COO & CFO
Transactions
- Award
Employee Stock Option
2026-01-05+175,000→ 175,000 totalExercise: $3.18Exp: 2036-01-05→ Common Stock (175,000 underlying)
Footnotes (2)
- [F1]Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
- [F2]The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026.